Purpose: Ileostomy formation requires major dietary adjustments to prevent complications and maintain nutritional status, yet dietary advice is often inconsistent, and evidence guiding best practice remains limited. This study explored how people living with an ileostomy (ileostomates) and healthcare professionals (HCPs) experience and support dietary management, uniquely comparing UK and Australian perspectives. Method: Fifty semi-structured interviews were conducted with ileostomates ( n = 26) and HCPs ( n = 12 stoma care nurses, n = 12 dietitians) across the UK and Australia. Interviews were recorded, transcribed and analysed using thematic content analysis guided by the Social Ecological Model (SEM). Results: Seven main categories emerged, spanning intrapersonal, interpersonal, community, institutional and public policy factors. Ileostomates reported persistent dietary restriction, fear of food bolus blockages, and reliance on online forums when HCP follow up was limited. HCP transcripts highlighted variations in practice, constrained caseloads, and gaps in evidence underpinning dietary guidance. Country-specific differences were observed, with Australian ileostomates emphasising hydration and geographical barriers. HCPs in the UK highlighted reinforcement of advice from a stoma nurse or dietitian as being central to dietary reintroduction, whereas their Australian counterparts prioritised a patient-led approach. Conclusion: Findings reveal systemic gaps in dietary support across both countries and highlight the need for individualised support, improved professional training, and integration of digital or telehealth solutions to enhance accessibility and continuity of care.
Objectives: The prevalence of stoma formation in the United Kingdom has risen markedly over the past decade, yet comparatively little is known about national prescribing patterns for ostomy products. A retrospective cross-sectional observational study was conducted in which the UK Prescription Cost Analysis (PCA) data for 2023 were examined to assess what information can be extracted from these datasets, to evaluate inter-nation variation in prescribing, and identify areas warranting further health economics and policy investigation. Methods: PCA data for calendar year 2023 were collated from the four devolved UK health services. Data on product type, manufacturer, quantities dispensed, and cost were compared across nations and product categories. Results: Total UK prescription spend on ostomy products in 2023 was £457 million, 3.4% of overall NHS prescription expenditure. Pouches accounted for 72% (£329 million) of spend, with the remainder supporting peristomal skin health and appliance adhesion. Estimated average per-patient spend was modelled and varied substantially by nation, from £1073 in Wales to £2354 in England, against a UK average of £2243. Persistent prescribing of ancillary items no longer recommended for routine use (filters, deodorants, bag covers) accounted for an estimated £ 8 million (>2% of spend). Conclusions: PCA data represent an underutilized resource for population-level analysis of ostomy care. Marked inter-nation variation in expenditure, uncertainty surrounding ostomate population estimates, and the continued prescribing of ancillary items not recommended for routine use identify important evidence gaps and generate hypotheses for future research with direct relevance to prescribing policy, resource allocation, and equitable access to care across the United Kingdom.
Meat and meat products are one of the largest contributors to vitamin D dietary intakes. Little is known, however, about how different animal husbandry practices and/or finishing diets might affect the vitamin D content of the animal. Therefore, this study aimed to investigate the effect of bovine finishing diet (grass vs. concentrate) on the 25(OH)D plasma concentrations of cattle and subsequent vitamin D content in beef. Cattle were fed grass (n = 7) or concentrate (n = 9) finishing diets for 15 weeks prior to slaughter. Bovine blood samples were collected at slaughter and plasma aliquots were stored (−80 °C) until analysis. Beef top rump from each animal was chilled for an ageing period of 21 days, then homogenised and frozen (−80 °C) until analysis. Bovine plasma samples were analysed for circulating 25(OH)D3, and 25(OH)D2 (nmol/L), and raw beef muscle (top rump) samples were analysed for vitamin D metabolites; vitamin D3, vitamin D2, 25(OH)D3 and 25(OH)D2 (µg/kg), all by LC-MS/MS. Total vitamin D activity was defined: [vitamin D3 + (25(OH)D3 × 5) + vitamin D2 + (25(OH)D2 × 5)]. Statistical analysis was conducted by SPSS with independent t tests used to compare groups; significance level p < 0.05. Data were presented as mean ± SD. A significantly higher plasma 25(OH)D2 concentration was observed in the grass finished cattle compared to the concentrate group (43.18 ± 11.75 vs. 16.56 ± 1.58 nmol/L, p < 0.002). No difference in plasma 25(OH)D3 concentrations was observed between groups. In beef top rump, the grass finishing diet resulted in a significantly higher mean ± SD vitamin D2 [0.07 ± 0.05 vs. 0.01 ± 0.01 µg/kg] and 25(OH)D2 [0.70 ± 0.16 vs. 0.25 ± 0.07 µg/kg] compared to concentrate finishing diet (both p < 0.001). Moreover, beef from grass finished cattle demonstrated a significantly higher total vitamin D activity compared to those in the concentrate group [9.52 ± 2.43 vs. 6.78 ± 2.00 µg/kg, p < 0.05]. No difference was observed for muscle vitamin D3 or 25(OH)D3 between groups. In conclusion, a more favourable bovine vitamin D profile, driven by vitamin D2 metabolites specifically (not vitamin D3), is reported from a grass-based finished system, compared to concentrate finishing. Further research is required to understand the impact of these findings for both agriculture practices and human nutrition.
Vitamin D-(bio)enriched meat products may complement current market offerings to produce value-added foods without altering consumer dietary habi | POSTER